Abstract: The present invention relates to a compressed solid composition for MRI comprising a physiologically acceptable manganese (II) compound, its preparation and use for preparing an oral solution.
Type:
Application
Filed:
June 8, 2020
Publication date:
August 18, 2022
Applicant:
Ascelia Pharma AB
Inventors:
Bent Højgaard, Magnus Olafsson Corfitzen, Dorthe Da Graca Couto Thrige
Abstract: The present invention relates to a compressed solid composition for MRI comprising a physiologically acceptable manganese (II) compound, its preparation and use for preparing an oral solution.
Type:
Grant
Filed:
June 8, 2020
Date of Patent:
February 9, 2021
Assignee:
Ascelia Pharma AB
Inventors:
Bent Højgaard, Magnus Olafsson Corfitzen, Dorthe Da Graca Couto Thrige